Retraction Note: KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling (Nature, (2013), 498, 7452, (70-74), 10.1038/nature12201);KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling

Nature

Volumn 498, Issue 7452, 2013, Pages 70-74

  Kaidi, Abderrahmane ^a   Jackson, Stephen P ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLTRANSFERASE KAT5; ACYLTRANSFERASE; ATM PROTEIN; UNCLASSIFIED DRUG;

DNA; ENZYME; LESION; PROTEIN; SIGNALING; SURVIVAL;

ACETYLATION; ARTICLE; AUTOPHOSPHORYLATION; BINDING KINETICS; BIOACCUMULATION; CELL SURVIVAL; CHROMATIN; DNA DAMAGE CHECKPOINT; ENZYME ACTIVITY; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GENOMICS; HALF LIFE TIME; HELA CELL; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IONIZING RADIATION; M PHASE CELL CYCLE CHECKPOINT; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTO ONCOGENE; RADIATION EXPOSURE; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 84878677036     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-019-1142-2     Document Type: Erratum

References (35)

1. Jackson, S. P. & Bartek, J. The DNA-damage response in human biology and disease. Nature 461, 1071-1078 (2009).
2. Harper, J. W. & Elledge, S. J. The DNA damage response: ten years after. Mol. Cell 28, 739-745 (2007).
3. Miller, K. M. & Jackson, S. P. Histone marks: repairing DNA breaks within the context of chromatin. Biochem. Soc. Trans. 40, 370-376 (2012).
4. Downs, J. A., Nussenzweig, M. C. & Nussenzweig, A. Chromatin dynamics and the preservation of genetic information. Nature 447, 951-958 (2007).
5. Bartek, J. & Lukas, J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr. Opin. Cell Biol. 19, 238-245 (2007).
6. Shiloh, Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31, 402-410 (2006).
7. Lee, J.-H. & Paull, T. T. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304, 93-96 (2004).
8. Lee, J.-H. & Paull, T. T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308, 551-554 (2005).
9. Falck, J., Coates, J. & Jackson, S. P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434, 605-611 (2005).
10. Uziel, T. et al. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22, 5612-5621 (2003).
11. Ayoub, N., Jeyasekharan, A. D., Bernal, J. A. & Venkitaraman, A. R. HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response. Nature 453, 682-686 (2008).
12. Sun, Y. et al. Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60. Nature Cell Biol. 11, 1376-1382 (2009).
13. Sun, Y., Xu, Y., Roy, K. & Price, B. D. DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity. Mol. Cell. Biol. 27, 8502-8509 (2007).
14. Kimura, A. & Horikoshi, M. Tip60 acetylates six lysines of a specific class in core histones in vitro. Genes Cells 3, 789-800 (1998).
15. Sun, Y., Jiang, X., Chen, S., Fernandes, N. & Price, B. D. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl Acad. Sci. USA 102, 13182-13187 (2005).
16. Ziv, Y. et al. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM-and KAP-1 dependent pathway. Nature Cell Biol. 8, 870-876 (2006).
17. Kruhlak, M. J. et al. Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks. J. Cell Biol. 172, 823-834 (2006).
18. Bakkenist, C. J.&Kastan, M. B.DNAdamage activates ATMthrough intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506 (2003).
19. Hickson, I. et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64, 9152-9159 (2004).
20. Shafman, T. et al. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387, 520-523 (1997).
21. Meltser, V., Ben-Yehoyada, M.& Shaul, Y. c-Abl tyrosine kinase in the DNA damage response: cell death and more. Cell Death Differ. 18, 2-4 (2011).
22. Wang, X. et al. A positive role for c-Abl in Atm and Atr activation in DNA damage response. Cell Death Differ. 18, 5-15 (2011).
23. Kharbanda, S. et al. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376, 785-788 (1995).
24. Baskaran, R. et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516-519 (1997).
25. Buchdunger, E. et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res. 56, 100-104 (1996).
26. Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560 (2007).
27. Edmunds, J. W., Mahadevan, L. C.& Clayton, A. L. Dynamic histone H3methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J. 27, 406-420 (2008).
28. Chantalat, S. et al. Histone H3 trimethylation at lysine 36 is associated with constitutive and facultative heterochromatin. Genome Res. 21, 1426-1437 (2011).
29. Jiang, Z. et al. Tip60-mediated acetylation activates transcription independent apoptotic activity of Abl. Mol. Cancer 10, 88 (2011).
30. Brasher, B. B. & Van Etten, R. A. c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines. J. Biol. Chem. 275, 35631-35637 (2000).
31. Scaffidi, P. & Misteli, T. Lamin A-dependent nuclear defects in human aging. Science 312, 1059-1063 (2006).
32. Pegoraro, G.&Misteli, T. The central role of chromatin maintenance in aging. Aging (Albany NY) 1, 1017-1022 (2009).
33. Pegoraro, G. et al. Ageing-related chromatin defects through loss of the NURD complex. Nature Cell Biol. 11, 1261-1267 (2009).
34. Lane, A. A.&Chabner, B. A. Histone deacetylase inhibitors in cancer therapy. J. Clin. Oncol. 27, 5459-5468 (2009).
35. Podtcheko, A. et al. Inhibition of ABL tyrosine kinase potentiates radiation-induced terminal growth arrest in anaplastic thyroid cancer cells. Radiat. Res. 165, 35-42 (2006).